GT199900192A - Nuevos antibioticos macrolidos. - Google Patents
Nuevos antibioticos macrolidos.Info
- Publication number
- GT199900192A GT199900192A GT199900192A GT199900192A GT199900192A GT 199900192 A GT199900192 A GT 199900192A GT 199900192 A GT199900192 A GT 199900192A GT 199900192 A GT199900192 A GT 199900192A GT 199900192 A GT199900192 A GT 199900192A
- Authority
- GT
- Guatemala
- Prior art keywords
- birds
- mammals
- new
- fishes
- invention refers
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 3
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
ESTA INVENCION SE REFIERE A NUEVOS DERIVADOS MACROLIDOS QUE SON UTILES COMO AGENTES ANTIBACTERIANOS Y ANTIPROTOZOARIOS EN MAMIFEROS, INCLUYENDO EL SER HUMANO, ASI COMO A PECES Y AVES, ESTA INVENCION SE REFIERE ADEMAS A COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS NUEVOS COMPUESTOS Y A PROCEDIMIENTOS DE TRATAMIENTO DE INFECCIONES BACTERIANAS Y POR PROTOZOOS Y TRASTORNOS RELACIONADOS CON INFECCIONES BACTERIANAS, COMO LA ATEROSCLEROSIS Y EL CANCER EN MAMIFEROS, PECES Y AVES, ADMINISTRANDO LOS NUEVOS COMPUESTOS A MAMIFEROS, PECES Y AVES QUE NECESITEN DICHO TRATAMIENTO. LA ESTRUCTURA SE SEÑALA COMO FORMULA I, DONDE EL NOMBRE ESPECIFICO DE LAS POSIBILIDADES DE SUSTITUCION DE GRUPOS FUNCIONALES SE HALLAN LISTADOS EN EL DOCUMENTO ORIGINAL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10683698P | 1998-11-03 | 1998-11-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT199900192A true GT199900192A (es) | 2001-04-26 |
Family
ID=22313524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT199900192A GT199900192A (es) | 1998-11-03 | 1999-11-03 | Nuevos antibioticos macrolidos. |
Country Status (34)
Country | Link |
---|---|
US (3) | US20020040007A1 (es) |
EP (1) | EP1124837A2 (es) |
JP (1) | JP4043191B2 (es) |
KR (1) | KR20010083944A (es) |
CN (1) | CN1376160A (es) |
AP (1) | AP2001002131A0 (es) |
AU (1) | AU5995299A (es) |
BG (1) | BG105543A (es) |
BR (1) | BR9914998A (es) |
CA (1) | CA2349338C (es) |
CO (1) | CO5140110A1 (es) |
CZ (1) | CZ20011512A3 (es) |
EA (1) | EA200100396A1 (es) |
EE (1) | EE200100245A (es) |
GT (1) | GT199900192A (es) |
HK (1) | HK1049010A1 (es) |
HR (1) | HRP20010306A2 (es) |
HU (1) | HUP0104192A3 (es) |
ID (1) | ID28286A (es) |
IL (1) | IL142628A0 (es) |
IS (1) | IS5919A (es) |
MA (1) | MA26703A1 (es) |
NO (1) | NO20012155L (es) |
OA (1) | OA11670A (es) |
PA (1) | PA8485101A1 (es) |
PE (1) | PE20001289A1 (es) |
PL (1) | PL348114A1 (es) |
SK (1) | SK5812001A3 (es) |
SV (1) | SV1999000188A (es) |
TN (1) | TNSN99205A1 (es) |
TR (4) | TR200101241T2 (es) |
UY (1) | UY25780A1 (es) |
WO (1) | WO2000026224A2 (es) |
ZA (1) | ZA200103289B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP9801420A0 (en) * | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
CA2349338C (en) | 1998-11-03 | 2005-12-06 | Pfizer Products Inc. | Novel macrolide antibiotics |
KR20020002380A (ko) | 1999-01-27 | 2002-01-09 | 실버스타인 아써 에이. | 케톨라이드 항생물질 |
US6590083B1 (en) | 1999-04-16 | 2003-07-08 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
US6939861B2 (en) | 1999-04-16 | 2005-09-06 | Kosan Biosciences, Inc. | Amido macrolides |
US6514944B2 (en) | 1999-04-16 | 2003-02-04 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
NZ515027A (en) | 1999-04-16 | 2004-01-30 | Kosan Biosciences Inc | Erythromycin derivatives as antibiotics |
US6451768B1 (en) | 1999-04-16 | 2002-09-17 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
WO2000062783A2 (en) | 1999-04-16 | 2000-10-26 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
EA200100983A1 (ru) | 1999-05-24 | 2002-10-31 | Пфайзер Продактс Инк. | Производные 13-метилэритромицина |
EP1114826A3 (en) * | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Novel antibacterial and prokinetic macrolides |
EP1146051A3 (en) * | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Erythromycin A derivatives |
PT1167376E (pt) | 2000-06-30 | 2004-09-30 | Pfizer Prod Inc | Antibioticos macrolidos |
RU2397987C2 (ru) * | 2004-07-28 | 2010-08-27 | Рэнбакси Лабораториз Лимитед | Кетолидные производные в качестве антибактериальных агентов |
WO2006046112A2 (en) * | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Ketolide derivatives as antibacterial agents |
EP1836211B1 (en) | 2004-12-21 | 2010-03-03 | Pfizer Products Inc. | Macrolides |
EP1960413A2 (en) * | 2005-11-23 | 2008-08-27 | Ranbaxy Laboratories Limited | Macrolides derivatives as antibacterial agents |
EP1957508A2 (en) * | 2005-11-23 | 2008-08-20 | Ranbaxy Laboratories Limited | Ketolide derivatives as antibacterial agents |
US7801502B2 (en) * | 2006-12-18 | 2010-09-21 | Aai Corporation | Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems |
US8409628B2 (en) | 2010-02-04 | 2013-04-02 | Penguin IP Holdings, Inc. | Methods and compositions for oxygenation of skin to treat skin disorders |
US8900601B2 (en) | 2010-03-31 | 2014-12-02 | Jennifer Bartels | Permeable mixtures, methods and compositions for the skin |
NZ713615A (en) * | 2013-05-01 | 2020-05-29 | Neoculi Pty Ltd | Methods for treating bacterial infections |
RU2537143C1 (ru) * | 2013-11-08 | 2014-12-27 | Государственное научное учреждение Ставропольский научно-исследовательский институт животноводства и кормопроизводства РАСХН | Препарат для лечения и профилактики мастита у коров |
WO2018080072A2 (ko) * | 2016-10-27 | 2018-05-03 | 한국생명공학연구원 | 신규한 매크로라이드계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 말라리아의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU43006B (en) * | 1981-03-06 | 1989-02-28 | Pliva Pharm & Chem Works | Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof |
US4474768A (en) * | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of the history of erythromycin |
US5527780A (en) | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
FR2697524B1 (fr) * | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
US5332807A (en) | 1993-04-14 | 1994-07-26 | Merck & Co., Inc. | Process of producing 8A- and 9A-azalide antibiotics |
FR2702480B1 (fr) * | 1993-03-09 | 1995-04-28 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
HRP931480B1 (en) | 1993-12-08 | 1997-08-31 | Sour Pliva | 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A |
HRP950145A2 (en) | 1995-03-27 | 1997-08-31 | Sour Pliva | New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof |
HN1996000101A (es) | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
CA2253338C (en) * | 1996-05-07 | 2007-05-08 | Abbott Laboratories | 6-o-substituted erythromycins and method for making them |
DK0910633T3 (da) | 1996-07-05 | 2010-03-29 | Biotica Tech Ltd | Hybrid polyketidsyntase I-gen |
UA51730C2 (uk) * | 1996-09-04 | 2002-12-16 | Ебботт Лабораторіз | 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців |
ATE299508T1 (de) * | 1996-09-04 | 2005-07-15 | Abbott Lab | 6-o-substituierte ketoliden mit antibakteriellen wirkung |
HRP960497B1 (en) | 1996-10-28 | 2003-08-31 | Pliva Pharm & Chem Works | 9-n-ethenyl derivatives of 9(s)-erythromycylamine |
US6407074B1 (en) | 1997-06-11 | 2002-06-18 | Pfizer Inc | C-4″-substituted macrolide derivatives |
HN1998000074A (es) | 1997-06-11 | 1999-01-08 | Pfizer Prod Inc | Derivados de macrolidos c-4 sustituidos |
EP0895999A1 (en) | 1997-08-06 | 1999-02-10 | Pfizer Products Inc. | C-4" substituted macrolide antibiotics |
US6339063B1 (en) | 1997-09-10 | 2002-01-15 | Merck & Co., Inc. | 9a-azalides as veterinary antimicrobial agents |
NZ503897A (en) | 1997-10-16 | 2002-10-25 | Pliva Pharm & Chem Works | 3,6-hemiketals from the class of 9a-azalides |
PT941998E (pt) | 1998-03-03 | 2004-12-31 | Pfizer Prod Inc | Antibioticos macrolidos do tipo 3,6-cetal |
CA2349338C (en) | 1998-11-03 | 2005-12-06 | Pfizer Products Inc. | Novel macrolide antibiotics |
EA200100983A1 (ru) | 1999-05-24 | 2002-10-31 | Пфайзер Продактс Инк. | Производные 13-метилэритромицина |
EP1114826A3 (en) | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Novel antibacterial and prokinetic macrolides |
EP1122261A3 (en) | 2000-01-31 | 2001-09-26 | Pfizer Products Inc. | 13 and 14-membered antibacterial macrolides |
PT1167376E (pt) | 2000-06-30 | 2004-09-30 | Pfizer Prod Inc | Antibioticos macrolidos |
JP4509553B2 (ja) | 2001-07-03 | 2010-07-21 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 抗菌活性を有するc12修飾エリスロマイシンマクロライドおよびケトライド |
-
1999
- 1999-10-18 CA CA002349338A patent/CA2349338C/en not_active Expired - Fee Related
- 1999-10-18 HU HU0104192A patent/HUP0104192A3/hu unknown
- 1999-10-18 EE EEP200100245A patent/EE200100245A/xx unknown
- 1999-10-18 EA EA200100396A patent/EA200100396A1/ru unknown
- 1999-10-18 BR BR9914998-2A patent/BR9914998A/pt not_active IP Right Cessation
- 1999-10-18 CN CN99812941A patent/CN1376160A/zh active Pending
- 1999-10-18 ID IDW20010956D patent/ID28286A/id unknown
- 1999-10-18 JP JP2000579612A patent/JP4043191B2/ja not_active Expired - Fee Related
- 1999-10-18 TR TR2001/01241T patent/TR200101241T2/xx unknown
- 1999-10-18 OA OA1200100102A patent/OA11670A/en unknown
- 1999-10-18 AU AU59952/99A patent/AU5995299A/en not_active Abandoned
- 1999-10-18 CZ CZ20011512A patent/CZ20011512A3/cs unknown
- 1999-10-18 KR KR1020017005535A patent/KR20010083944A/ko not_active Application Discontinuation
- 1999-10-18 PL PL99348114A patent/PL348114A1/xx not_active Application Discontinuation
- 1999-10-18 EP EP99971424A patent/EP1124837A2/en not_active Withdrawn
- 1999-10-18 SK SK581-2001A patent/SK5812001A3/sk unknown
- 1999-10-18 TR TR2002/00435T patent/TR200200435T2/xx unknown
- 1999-10-18 TR TR2002/00434T patent/TR200200434T2/xx unknown
- 1999-10-18 AP APAP/P/2001/002131A patent/AP2001002131A0/en unknown
- 1999-10-18 WO PCT/IB1999/001701 patent/WO2000026224A2/en not_active Application Discontinuation
- 1999-10-18 IL IL14262899A patent/IL142628A0/xx unknown
- 1999-10-18 TR TR2002/00436T patent/TR200200436T2/xx unknown
- 1999-10-29 UY UY25780A patent/UY25780A1/es unknown
- 1999-10-29 PE PE1999001084A patent/PE20001289A1/es not_active Application Discontinuation
- 1999-10-29 SV SV1999000188A patent/SV1999000188A/es not_active Application Discontinuation
- 1999-11-02 MA MA25832A patent/MA26703A1/fr unknown
- 1999-11-02 PA PA19998485101A patent/PA8485101A1/es unknown
- 1999-11-02 TN TNTNSN99205A patent/TNSN99205A1/fr unknown
- 1999-11-03 CO CO99069359A patent/CO5140110A1/es unknown
- 1999-11-03 GT GT199900192A patent/GT199900192A/es unknown
-
2001
- 2001-04-17 IS IS5919A patent/IS5919A/is unknown
- 2001-04-23 ZA ZA200103289A patent/ZA200103289B/xx unknown
- 2001-04-30 HR HR20010306A patent/HRP20010306A2/hr not_active Application Discontinuation
- 2001-05-02 NO NO20012155A patent/NO20012155L/no not_active Application Discontinuation
- 2001-05-29 BG BG105543A patent/BG105543A/xx unknown
- 2001-10-01 US US09/969,486 patent/US20020040007A1/en not_active Abandoned
-
2002
- 2002-07-24 US US10/206,652 patent/US6835716B2/en not_active Expired - Fee Related
-
2003
- 2003-02-18 HK HK03101144.0A patent/HK1049010A1/zh unknown
-
2004
- 2004-07-21 US US10/896,293 patent/US7071170B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT199900192A (es) | Nuevos antibioticos macrolidos. | |
PA8524501A1 (es) | Antibioticos macrolidos | |
GT199900198A (es) | Azalidas de 13 miembros y su uso como agentes antibioticos. | |
UY25330A1 (es) | Nuevos macrólidos | |
GT199800075A (es) | Derivados de macrolidos c-4" sustituidos. | |
PA8461701A1 (es) | Derivados de 9-amino-3-ceto eritromicina | |
GT199800074A (es) | Derivados de la 9-oxima eritromicina. | |
HN2000000003A (es) | Antibioticos cetolidos | |
ECSP055681A (es) | Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante (tgf) | |
PA8583101A1 (es) | Nuevos compuestos de isotiazol e isoxazol como inhibidores del factor de crecimiento transformador (tgf) | |
PA8583301A1 (es) | Nuevos compuestos de imidazol como inhibidores del factor de crecimiento transformante (tgf) | |
ES2183937T3 (es) | Inhibidores de la adhesion celular. | |
HN1999000080A (es) | Derivados de isotiazol utiles como agentes anticancerosos. | |
ECSP055679A (es) | Derivados de pirazol como inhibidores del factor del crecimiento transformante (tgf) | |
PA8462401A1 (es) | Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos | |
HN2000000268A (es) | Compuestos , composiciones y metodos para estimular el crecimiento y elongacion de neuronas | |
ES2111450B1 (es) | Composicion de perlas de cemento para la cirugia ortopedica y su procedimiento de fabricacion. | |
AR005642A1 (es) | Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios | |
PA8461401A1 (es) | Derivados de eritromicina triciclicos | |
GT199900064A (es) | Derivados de higromicina a. | |
AR025379A1 (es) | 9a-azalidas con actividad antibacteriana. | |
BR0015722A (pt) | Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas | |
ES2144154T3 (es) | Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica. | |
BR0114703A (pt) | Uso de 3-o-acetil-4"-o- isovaleril-tilosina ou um sal de adição de ácido farmacologicamente, aceitável ou outro derivado da mesma, ração para aves de criação e suìnos, composição revestida estável para adição a uma ração animal, e, medicamento veterinário | |
GT199900153A (es) | Antibiòticos de carbamato y carbamato cetolida.- |